Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate-Reference-Cited by-同舟云学术

Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate

Published:2021-06 Issue:6 Volume:1865 Page:129893
ISSN:0304-4165
Container-title:Biochimica et Biophysica Acta (BBA) - General Subjects
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - General Subjects

Author:

Chen Wen-Hsiang,Wei Junfei,Kundu Rakhi Tyagi,Adhikari Rakesh,Liu Zhuyun,Lee Jungsoon,Versteeg Leroy,Poveda Cristina,Keegan Brian,Villar Maria Jose,de Araujo Leao Ana C.,Rivera Joanne Altieri,Gillespie Portia M.,Pollet Jeroen,Strych Ulrich,Zhan Bin,Hotez Peter J.,Bottazzi Maria Elena

Funder

Robert J Kleberg Jr and Helen C Kleberg Foundation

National Institutes of Health

JPB Foundation

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference56 articles.

1. An interactive web-based dashboard to track COVID-19 in real time;Dong;Lancet Infect. Dis.,2020

2. Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome;Jiang;Exp. Rev. Vaccin.,2012

3. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model;Du;Vaccine,2007